Search results for "Hamilton Rating Scale for Depression"

showing 10 items of 15 documents

Neurocognitive impairment and psychosocial functioning in bipolar II disorder

2011

Sole B, Bonnin CM, Torrent C, Balanza-Martinez V, Tabares-Seisdedos R, Popovic D, Martinez-Aran A, Vieta E. Neurocognitive impairment and psychosocial functioning in bipolar II disorder. Objective:  There is a growing body of evidence on neurocognitive impairment in euthymic bipolar patients, but this issue has been studied mostly in bipolar I disorder, data on bipolar II (BD-II) are scant and discrepant. The two aims of this study were to ascertain whether strictly defined euthymic BD-II patients would present neurocognitive disturbances and to evaluate their impact on functional outcome. Method:  Forty-three BD-II patients and 42 demographically and educationally matched healthy subjects …

medicine.medical_specialtyBipolar I disorderTrail Making TestHamilton Rating Scale for DepressionVerbal learningmedicine.diseaseYoung Mania Rating ScalePsychiatry and Mental healthBipolar II disorderHypomaniamedicinemedicine.symptomPsychologyPsychiatryNeurocognitiveActa Psychiatrica Scandinavica
researchProduct

Treatment nonadherence and neurocognitive impairment in bipolar disorder.

2009

OBJECTIVE: Little is known regarding the relationship between treatment adherence and residual cognitive dysfunction in euthymic bipolar disorder patients. This study aimed to investigate whether poor treatment adherence is associated with cognitive impairment in euthymic bipolar patients and whether other factors may be associated with both adherence and cognitive functioning. METHOD: Euthymic DSM-IV bipolar I or II disorder patients (N = 103: 61 with high levels of treatment adherence and 42 with poor treatment adherence) were assessed using a neuropsychological battery targeting attention, psychomotor speed, verbal memory, and executive functions and compared with 35 healthy controls of …

AdultMalemedicine.medical_specialtyBipolar DisorderComorbidityNeuropsychological TestsYoung Mania Rating ScaleVerbal learningSeverity of Illness IndexMemorymedicineHumansBipolar disorderPsychiatryPsychiatric Status Rating ScalesCognitive disorderHamilton Rating Scale for DepressionVerbal Learningmedicine.diseaseExecutive functionsDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthPatient ComplianceFemaleVerbal memoryPsychologyCognition DisordersLithium ChlorideNeurocognitivePsychomotor PerformanceClinical psychologyThe Journal of clinical psychiatry
researchProduct

Latencies of the P300 component of the auditory event-related potential in depression are related to the Bech-Rafaelsen Melancholia Scale but not to …

1991

The relationship between severity of depression and the P300 latency of auditory event-related potential was investigated in 36 patients with a major depressive episode according to DSM-III. Positive correlations were found between of the P300 latency and the total score of the Bech-Rafaelsen Melancholia Scale (BRMS), the 4 retardation items of the BRMS (motor, verbal, intellectual and emotional) and the item for lowered mood. In contrast, latencies were not associated with the scores of the Hamilton Rating Scale for Depression, which considers retardation to a lesser extent than the BRMS.

AdultMalemedicine.medical_specialtyPsychometricsAuditory eventAudiologybehavioral disciplines and activitiesPitch DiscriminationRating scalemental disordersMelancholiaReaction TimemedicineHumansAttentionSomatoform DisordersPsychiatryMajor depressive episodeDepression (differential diagnoses)Cerebral CortexPsychiatric Status Rating ScalesDepressive DisorderHamilton Rating Scale for DepressionMiddle AgedAnxiety DisordersPsychiatry and Mental healthMoodEvoked Potentials AuditoryFemalemedicine.symptomPsychologyActa Psychiatrica Scandinavica
researchProduct

No relationship between baseline salivary alpha-amylase and State-Trait Anxiety Inventory Score in drug-naïve patients with short-illness-duration fi…

2016

BACKGROUND Salivary α-amylase (sAA) activity alternations are observed in major depressive disorder (MDD) being associated with depression severity and its specific psychopathological dimensions with anxiety being attributed to distress. No data is available on sAA in MDD according to Hamilton Rating Scale for Depression (HAMD-17) and State-Trait Anxiety Inventory (STAI). The exploratory study examines whether and to what extent baseline sAA level is interrelated to the psychopathological features including severity of symptoms and specific psychopathological dimensions. MATERIAL AND METHODS The basal, non-stimulated sAA activity was studied in 20 non-late-life adult, treatment-naive MDD pa…

medicine.medical_specialtybehavioral disciplines and activities03 medical and health sciences0302 clinical medicinemental disordersmedicinePsychiatryGeneral DentistryFirst episodebusiness.industryResearchHamilton Rating Scale for Depressionmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Community and Preventive Dentistry030227 psychiatryDrug-naïveDistressstomatognathic diseasesUNESCO::CIENCIAS MÉDICASMajor depressive disorderAnxietymedicine.symptombusiness030217 neurology & neurosurgeryState-Trait Anxiety Inventorymedicine.drugPsychopathologyJournal of clinical and experimental dentistry
researchProduct

Mirtazapine compared with paroxetine in major depression.

2000

Background: The aim was to compare the efficacy and tolerability of mirtazapine with those of paroxetine. Method: 275 outpatients with a diagnosis of major depressive episode (DSM-IV) and a score ≥ 18 on the 17-item Hamilton Rating Scale for Depression (HAM-D-17) were randomly assigned to 6 weeks of treatment with mirtazapine (15-45 mg/day) or paroxetine (20-40 mg/day). Efficacy was assessed by the HAM-D-17, Hamilton Rating Scale for Anxiety (HAM-A), and Clinical Global Impressions scales (Severity and Improvement), and analyses were performed on the intent-to-treat sample (127 mirtazapine-treated patients and 123 paroxetine-treated patients). Results: Mean daily doses were 32.7 mg of mirta…

AdultMalemedicine.medical_specialtyNauseaMirtazapineMirtazapineMianserinAntidepressive Agents TricyclicSeverity of Illness IndexDrug Administration Schedulelaw.inventionRandomized controlled trialDouble-Blind MethodlawInternal medicinemedicineAmbulatory CareHumansPsychiatryMajor depressive episodeAgedPsychiatric Status Rating ScalesDepressive DisorderHamilton Rating Scale for DepressionMiddle AgedParoxetinePsychiatry and Mental healthParoxetineTreatment OutcomeTolerabilityAnxietyFemalemedicine.symptomPsychologymedicine.drugThe Journal of clinical psychiatry
researchProduct

2019

Deficits in general emotion regulation skills have been shown to be associated with various mental disorders. Thus, general affect-regulation training has been proposed as promising transdiagnostic approach to the treatment of psychopathology. In the present study, we aimed to evaluate the efficacy of a general affect-regulation as a stand-alone, group-based treatment for depression. For this purpose, we randomly assigned 218 individuals who met criteria for major depressive disorder (MDD) to the Affect Regulation Training (ART), to a waitlist control condition (WLC), or to a condition controlling for common factors (CFC). The primary outcome was the course of depressive symptom severity as…

050103 clinical psychologyMultidisciplinarybusiness.industry05 social sciencesPsychological interventionBeck Depression InventoryHamilton Rating Scale for Depressionmedicine.disease030227 psychiatrylaw.invention03 medical and health sciencesEating disorders0302 clinical medicineRandomized controlled triallawmedicineMajor depressive disorder0501 psychology and cognitive sciencesbusinessDepression (differential diagnoses)Clinical psychologyPsychopathologyPLOS ONE
researchProduct

Neural and genetic correlates of antidepressant response to sleep deprivation - A functional magnetic resonance imaging study of moral valence decisi…

2007

Context: Total sleep deprivation combined with light therapy causes rapid amelioration of bipolar depression. A polymorphism in the promoter for the serotonin transporter influences both antidepressant response and the structure and function of specific brain areas. Objective: To determine whether antidepressant therapy or the genotype of the serotonin transporter influence the pattern of neural response to a task targeting the depressive biases in information processing (moral valence decision). Design: Before-and-after trial studying the biologic correlates of response to treatment. Setting: University hospital. Patients: Twenty inpatients with bipolar depression. Intervention: Repeated t…

Light therapyMaleBipolar DisorderGenotypemedicine.medical_treatmentDecision MakingMoralsJudgmentArts and Humanities (miscellaneous)medicineHumansBipolar disorderSerotonin transporterCerebral CortexChronotherapyPsychiatric Status Rating ScalesSerotonin Plasma Membrane Transport ProteinsSleep disorderDepressive Disorder MajorPolymorphism GeneticbiologyHamilton Rating Scale for DepressionMiddle AgedPhototherapymedicine.diseaseCombined Modality TherapyMagnetic Resonance ImagingHospitalizationOxygenPsychiatry and Mental healthSleep deprivationMoodTreatment Outcomebiology.proteinAntidepressantSleep DeprivationFemalemedicine.symptomPsychologyPsychomotor PerformanceClinical psychology
researchProduct

Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up

2007

Abstract Objective Many studies have reported that cognitive ability may be predictive of the functional outcome for patients with schizophrenia. However, no study has prospectively examined these aspects in schizophrenia and bipolar disorders simultaneously. The present study attempted to analyze if neurocognition and clinical status predicts the real-life functioning for patients with schizophrenia or bipolar I disorder, using a longitudinal design. Method Forty-seven schizophrenic and 43 bipolar I outpatients were assessed twice with a neurocognitive battery (Executive Functions, Working Memory, Verbal Memory, Visual Memory, Visual-Motor Processing, Vigilance, Vocabulary and Motor Speed …

Malemedicine.medical_specialtyBipolar DisorderBipolar I disorderGlobal Assessment of FunctioningSeverity of Illness IndexDisability EvaluationYoung AdultPredictive Value of Testsmental disordersmedicineHumansProspective StudiesBipolar disorderPsychiatryDemographyWechsler ScalesNeuropsychologyHamilton Rating Scale for Depressionmedicine.diseaseDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthClinical PsychologySchizophreniaFemaleVerbal memorymedicine.symptomCognition DisordersPsychologyNeurocognitiveManiaFollow-Up StudiesJournal of Affective Disorders
researchProduct

The association between burning mouth syndrome and sleep disturbance: A case-control multicentre study

2018

Objectives: To investigate the quality of sleep and the psychological profiles of a large cohort of Italian patients with burning mouth syndrome (BMS) and to clarify the relationships between these variables and pain. Methods: In this case–control study, 200 patients with BMS vs an equal number of age- and sex-matched healthy controls, recruited in 10 universities, were enrolled. The Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), Hamilton Rating Scale for Depression (HAM-D), Hamilton Rating Scale for Anxiety (HAM-A), Numeric Pain Intensity Scale (NRS) and Total Pain Rating Index (T-PRI) were administered. Descriptive statistics, including the Mann–Whitney U test and …

MaleAnxietyinsomnia symptomsPittsburgh Sleep Quality Indexanxiety burning insomnia symptoms mood disorders pain sleep0302 clinical medicinePrevalenceSleep Wake DisorderpainburningSleep disorderDepressionEpworth Sleepiness ScaleOtorhinolaryngology2734 Pathology and Forensic MedicineBurning mouth syndromeMiddle Agedanxietymood disordershumanitiesAnxietyFemalemedicine.symptomCase-Control StudieHumanAdultSleep Wake Disordersmedicine.medical_specialtyanxiety; burning; insomnia symptoms; mood disorders; pain; sleep; Otorhinolaryngology2734 Pathology and Forensic Medicine; Dentistry (all)anxiety; burning; insomnia symptoms; mood disorders; pain; sleepPainmood disorderBurning Mouth SyndromeSettore MED/28 - MALATTIE ODONTOSTOMATOLOGICHE03 medical and health sciencesRating scaleinsomnia symptommedicineHumanssleepGeneral DentistryAgedbusiness.industryHamilton Rating Scale for Depression030206 dentistrymedicine.diseaseMoodOtorhinolaryngologyCase-Control StudiesDentistry (all)Physical therapybusinessSleep030217 neurology & neurosurgery
researchProduct

Clinical Predictors of Response to Magnetic Seizure Therapy in Depression

2019

Objectives Magnetic seizure therapy (MST) is a novel convulsive brain stimulation method in clinical testing, which is used as an alternative for electroconvulsive therapy in patients with treatment-resistant depression (TRD). Preliminary studies have suggested that MST leads to fewer cognitive adverse effects than electroconvulsive therapy but has similar efficacy. However, the clinical predictors of response to MST have not been evaluated yet. This study aimed to investigate whether these predictors can be identified in patients with TRD. Methods Thirty-eight patients with TRD were included. As clinical predictors for treatment response, we used the diagnosis, sex, age, family history, an…

AdultMalemedicine.medical_specialtyAnhedoniaMagnetic Field Therapymedicine.medical_treatmentNeuroscience (miscellaneous)Depressive Disorder Treatment-Resistant03 medical and health sciences0302 clinical medicineElectroconvulsive therapyPredictive Value of TestsSeizuresInternal medicinemedicineHumansFamily historyAtypical depressionDepression (differential diagnoses)AgedPsychiatric Status Rating ScalesDepressionbusiness.industryHamilton Rating Scale for DepressionMiddle Agedmedicine.disease030227 psychiatryPsychiatry and Mental healthTreatment OutcomeMagnetic seizure therapyBrain stimulationAnxietyFemalemedicine.symptombusinesshuman activities030217 neurology & neurosurgeryThe Journal of ECT
researchProduct